A phase II study of Osimertinib for patients with radiotherapy-naïve CNS metastasis of non-small cell lung cancer: treatment rationale and protocol design of the OCEAN study (LOGIK 1603/WJOG 9116L)

Peer Review reports

Original Submission
2 Jan 2020	Submitted	Original manuscript
16 Feb 2020	Reviewed	Reviewer Report - Andrea De Giglio
4 Mar 2020	Reviewed	Reviewer Report - Qiuxiang Ou
27 Mar 2020	Author responded	Author comments - Kazushige Wakuda
31 Mar 2020	Reviewed	Reviewer Report - Qiuxiang Ou
1 Apr 2020	Reviewed	Reviewer Report - Andrea De Giglio
8 Apr 2020	Reviewed	Reviewer Report - Mohammad Ahmad al-Shatouri
15 Apr 2020	Author responded	Author comments - Kazushige Wakuda
Resubmission - Version 2
27 Mar 2020	Submitted	Manuscript version 2
Publishing
16 Apr 2020	Editorially accepted
1 May 2020	Article published	10.1186/s12885-020-06874-6

Back to article page